Exclusive sell-side advisor to the owners of Endomed on the sale of 100% stake to LUX MED
- Date: September 2026
- Country: Poland
- Industry: Healthcare
- Client: Endomed Janusz Romanowski sp. j. („Endomed”)
- Investor: Lux Med Sp. z o.o. („LUX MED”)
- Seller (Client): Founders of Endomed
- VCP Role: Sell-side M&A advisor
Transaction Highlights:
- VCP acted as sell-side M&A advisor to the founders of Endomed on the sale of 100% stake to LUX MED, Polish medical group owned by Bupa
- Endomed is a leading regional provider of gastroenterology-related services and operates a diversified platform of primary and specialist medical services
- Endomed has demonstrated strong revenue growth in recent years, supported by a long-standing relationship with the NFZ as well as a material share of revenue derived from private-pay patients
- The acquisition by LUX MED will be the group’s first medical center in Radom, providing a strategic foothold in the region
- VCP supported the founders of Endomed in the entire transaction process through provision of deal tactics, coordination of all work streams in the transaction process, assistance in negotiation strategy and other corporate finance assignments